What is it about?
Small conductance Ca2+-activated K+ channels are considered a promising new drug target to treat atrial fibrillation. Here we present a novel compound useful for studying the role of small conductance Ca2+-activated K+ channels in atrial fibrillation.
Featured Image
Read the Original
This page is a summary of: A new negative allosteric modulator, AP14145, for the study of small conductance calcium‐activated potassium (KCa2) channels, British Journal of Pharmacology, October 2017, Wiley,
DOI: 10.1111/bph.14043.
You can read the full text:
Contributors
The following have contributed to this page
